s6y
Company name or ticker
Search
Nurix Therapeutics, Inc.
4
Hansen Gwenn: Statement of changes in beneficial ownership of securities
Filed
Monday, November 2, 2026
Period
Oct 30, 2026
Accession number
0001817160-26-000023
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header